LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
Read in App
Business News » Companies News

Dr Reddy's PAT up 77 per cent at Rs 504 Cr in Q2

Dr Reddys Laboratories Limited Friday said its profit after tax for the quarter ended September 30 was up by 77 per cent to Rs 504 crore against Rs 387.6 crore in the second quarter of FY18.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Dr Reddy's PAT up 77 per cent at Rs 504 Cr in Q2
Revenues from Global Generics segment in the Q2 was reported at Rs 3050 crore a year-on-year growth of 7 per cent over the same quarter last year. Image courtesy: Reuters
Written By: PTI
Updated: Fri, Oct 26, 2018
05:12 pm
PTI
RELATED NEWS
 Dr Reddy's Q4 net profit rises by 319% Dr Reddy's Q4 net profit rises by 319%
Dr Reddy's Laboratories Q4 review: Here's what to expect Dr Reddy's Laboratories Q4 review: Here's what to expect
Dr Reddy's Q2 profit falls to Rs 31 crore Dr Reddy's Q2 profit falls to Rs 31 crore

Hyderabad: Dr Reddys Laboratories Limited Friday said its profit after tax for the quarter ended September 30 was up by 77 per cent to Rs 504 crore against Rs 387.6 crore in the second quarter of FY18.

According to a press release issued by the drug maker, revenues for the quarter under discussion was up by seven per cent to Rs 3798 crore. It was Rs 3546 crore in the same quarter last fiscal.

On the results, Co-chairman and CEO, G V Prasad said, "I am encouraged by our performance and progress in the second quarter. Our continuous focus on execution, operational efficiency and cost optimization are showing results.

Looking ahead, our priority will be to resolve pending regulatory issues, and continue to work on execution and cost structures that will enable affordable medicines for more patients."

Watch this Zee Business video here:

Revenues from Global Generics segment in the Q2 was reported at Rs 3050 crore a year-on-year growth of 7 per cent over the same quarter last year, primarily driven by contributions from Emerging Markets, India and favorable forex.

Revenues from Pharmaceutical Services and Active Ingredients was at Rs 600 crore in the second quarter with seven per cent growth over the Q2 of FY18.  

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Dr Reddys results
RELATED NEWS
 Dr Reddy's Q4 net profit rises by 319% Dr Reddy's Q4 net profit rises by 319%
Dr Reddy's Laboratories Q4 review: Here's what to expect Dr Reddy's Laboratories Q4 review: Here's what to expect
Dr Reddy's Q2 profit falls to Rs 31 crore Dr Reddy's Q2 profit falls to Rs 31 crore

LATEST NEWS

MTAR Technologies IPO Subscription details: Retail investors expect bumper listing

Easy Trip Planners IPO open for subscription, Anand Rathi says buy

Anil Singhvi’s Strategy March 8: Strong Profit Booking Zone on Nifty is 15,200-15,245 & Bank Nifty is 36,400-36,600

Toyota VC invests in AI startups, firms that refine everyday processes

MTAR IPO: Know allotment finalisation status, listing date and how to check subscription of shares

Exclusive: In chat with Anil Singhvi, SCI CMD Harjeet Kaur Joshi talks about divestment, business outlook and much more

Yes Bank Share price: Target price Rs 14, Anand Rathi maintains Sell rating | Earning, valuation and key risks

Happy International Women's Day: Send best WhatsApp wishes, quotes, messages to your loved ones

Karnataka Budget 2021: Big gift for Ram Temple Ayodhya pilgrims - All details here

Mid-Cap Picks with Anil Singhvi: JB Chemicals, Jindal Saw and KEC International are stocks to buy

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved